These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 2112488)

  • 1. Skin microcirculation and regional peripheral resistance in patients with chronic renal anaemia treated with recombinant human erythropoietin.
    Creutzig A; Caspary L; Nonnast-Daniel B; Bahlmann J; Kühn K; Brunkhorst R; Reimers E; Koch KM; Alexander K
    Eur J Clin Invest; 1990 Apr; 20(2):219-23. PubMed ID: 2112488
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-term effects of recombinant human erythropoietin on macro- and microcirculation in chronic hemodialysis patients.
    Wirtz JJ; Leunissen KM; van Kuijk W; Cheriex EC; Slaaf DW; Reneman RS; van Hooff JP
    Blood Purif; 1993; 11(4):237-47. PubMed ID: 8297565
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term effects of treatment with recombinant human erythropoietin on haemodynamics and tissue oxygenation in patients with renal anaemia.
    Nonnast-Daniel B; Deschodt G; Brunkhorst R; Creutzig A; Bahlmann J; Shaldon S; Koch KM
    Nephrol Dial Transplant; 1990; 5(6):444-8. PubMed ID: 2122322
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recombinant human erythropoietin and its effects on macro- and microcirculation during normovolemia. A physiological study of hemodynamics, fluid status and skin microcirculation.
    Wirtz JJ; Leunissen KM; van Esser JW; Cheriex EC; Slaaf DW; Reneman RS; van Hooff JP
    Blood Purif; 1990; 8(5):285-94. PubMed ID: 2091688
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of treatment with recombinant human erythropoietin on peripheral hemodynamics and oxygenation.
    Nonnast-Daniel B; Creutzig A; Kühn K; Bahlmann J; Reimers E; Brunkhorst R; Caspary L; Koch KM
    Contrib Nephrol; 1988; 66():185-94. PubMed ID: 3292147
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of human recombinant erythropoietin on anaemia, systemic haemodynamics and renal function in predialysis renal failure patients.
    Onoyama K; Kumagai H; Takeda K; Shimamatsu K; Fujishima M
    Nephrol Dial Transplant; 1989; 4(11):966-70. PubMed ID: 2516888
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Peripheral microcirculatory blood flow in haemodialysis patients treated with erythropoietin.
    Taylor JE; Belch JJ; Henderson IS; Stewart WK
    Int Angiol; 1996 Mar; 15(1):33-8. PubMed ID: 8739534
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of anaemia of progressive renal failure with recombinant human erythropoietin. A preliminary report.
    Salim KA; Salim S; Mathew T
    J Assoc Physicians India; 1992 Jan; 40(1):42-3. PubMed ID: 1634463
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epoetin alfa. A review of its clinical efficacy in the management of anaemia associated with renal failure and chronic disease and its use in surgical patients.
    Dunn CJ; Wagstaff AJ
    Drugs Aging; 1995 Aug; 7(2):131-56. PubMed ID: 7579784
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The haemodynamic effects of correction of anaemia in haemodialysis patients using recombinant human erythropoietin.
    Abdulhadi MH; Fouad-Tarazi FM; Thomas T; Bravo EL; Paganini EP
    Nephrol Dial Transplant; 1990; 5 Suppl 1():102-8. PubMed ID: 2129437
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Peripheral hemodynamics, blood viscosity, and the renin-angiotensin system in hemodialysis patients under therapy with recombinant human erythropoietin.
    Steffen HM; Brunner R; Müller R; Degenhardt S; Pollok M; Lang R; Baldamus CA
    Contrib Nephrol; 1989; 76():292-8. PubMed ID: 2582783
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of erythropoietin treatment on tissue oxygenation in patients with severe transfusion dependent renal anaemia.
    Landgraf H; Grützmacher P; Garcia-Bartels C; Bergmann M; Ehrly AM; Schoeppe W
    Eur J Med; 1993; 2(7):393-7. PubMed ID: 8258026
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Short term correction of anaemia with recombinant human erythropoietin and reduction of cardiac output in end stage renal failure.
    Morris KP; Skinner JR; Hunter S; Coulthard MG
    Arch Dis Child; 1993 May; 68(5):644-8. PubMed ID: 8323333
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recombinant human erythropoietin for chronic renal failure anaemia in pre-dialysis patients.
    Cody J; Daly C; Campbell M; Donaldson C; Grant A; Khan I; Pennington S; Vale L; Wallace S; MacLeod A
    Cochrane Database Syst Rev; 2001; (4):CD003266. PubMed ID: 11687180
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Initial response to treatment with erythropoietin in anemia caused by chronic renal insufficiency].
    Sánchez Casajús A; Barrau J; Gómez Alamillo C; Jaurrieta F
    Sangre (Barc); 1990 Feb; 35(1):82-4. PubMed ID: 2333585
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Echocardiographic findings in hemodialysis patients treated with recombinant human erythropoietin: proposal for a hematocrit most beneficial to hemodynamics.
    Tagawa H; Nagano M; Saito H; Umezu M; Yamakado M
    Clin Nephrol; 1991 Jan; 35(1):35-8. PubMed ID: 2007294
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment of the anaemia of end-stage renal disease with recombinant human erythropoietin.
    Verbeelen D; Hauglustaine D; Sennesael J
    Neth J Med; 1988 Aug; 33(1-2):60-7. PubMed ID: 3247012
    [No Abstract]   [Full Text] [Related]  

  • 18. Human recombinant erythropoietin in the treatment of anaemia in chronic haemodialysis patients.
    Sulková S; Kvasnicka J; Kasl M; Kozlová J; Podrouzek P; Bartûsková J; Válek A
    Czech Med; 1990; 13(2-3):98-106. PubMed ID: 2245762
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Is it time for a paradigm shift? Is erythropoietin deficiency still the main cause of renal anaemia?
    Eschbach JW; Varma A; Stivelman JC
    Nephrol Dial Transplant; 2002; 17 Suppl 5():2-7. PubMed ID: 12091599
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cardiovascular consequences of renal anaemia and erythropoietin therapy.
    Eckardt KU
    Nephrol Dial Transplant; 1999 May; 14(5):1317-23. PubMed ID: 10344393
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.